Evaluating growth and health management in children with thalassemia
Growth Evaluation, Health Promotion, and Clinical Management in Children and Adolescents With Thalassemia
This study is testing ways to help children with thalassemia grow and stay healthy by checking their development and providing support and education on managing their health.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 369 (estimated) |
| Ages | N/A to 18 Years |
| Sex | All |
| Sponsor | Institute of Hematology & Blood Diseases Hospital, China Academic / other |
| Locations | 1 site (Tianjin, Tianjin Municipality) |
| Trial ID | NCT06931912 on ClinicalTrials.gov |
What this trial studies
This study focuses on children and adolescents with transfusion-dependent thalassemia in China, aiming to assess their growth and development through comprehensive evaluations. It will identify patients with growth issues and implement targeted MENBS clinical interventions, which include monitoring health indicators and providing education on health management. The study seeks to address significant health challenges faced by these patients, particularly growth retardation, which impacts their quality of life and economic burden on families.
Who should consider this trial
Good fit: Ideal candidates for this study are children and adolescents diagnosed with transfusion-dependent thalassemia who are 18 years old or younger.
Not a fit: Patients who do not have transfusion-dependent thalassemia or are older than 18 years may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve growth outcomes and overall health management for children with thalassemia.
How similar studies have performed: Other studies have shown success in managing growth and health issues in pediatric thalassemia patients, indicating that this approach is supported by prior research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subjects diagnosed with transfusion-dependent thalassemia (TDT) * Male or female age ≤18 years * Subjects who are willing and able to provide written informed consent Exclusion Criteria: * Not applicable
Where this trial is running
Tianjin, Tianjin Municipality
- Regenerative Medicine Center and Red Blood Cell Disorders Center — Tianjin, Tianjin Municipality, China (Recruiting)
Study contacts
- Study coordinator: Jingyu Zhao, MPH
- Email: zhaojingyu@ihcams.ac.cn
- Phone: 13752253515
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.